ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PEDRO ROMAN EYXARCH MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 551

$603K Total Retail Price of All Prescriptions

Rank: 58 out of 551

754 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 14,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,526 1,224 1 1
METFORMIN HCL 637 480 2 2
AMLODIPINE BESYLATE 628 538 3 4
OMEPRAZOLE 616 482 4 7
GABAPENTIN 611 453 5 3
LEVOTHYROXINE SODIUM 581 480 6 9
ENALAPRIL MALEATE 527 388 7 5
METOPROLOL SUCCINATE 494 414 8 23
LOSARTAN-HYDROCHLOROTHIAZIDE 475 359 9 10
RANITIDINE HCL 446 368 10 8
LOSARTAN POTASSIUM 432 344 11 6
GLIMEPIRIDE 415 349 12 16
SYNTHROID 373 287 13 11
HYDROCHLOROTHIAZIDE 294 239 14 15
TRAMADOL HCL-ACETAMINOPHEN 288 214 15 18
ZOLPIDEM TARTRATE 273 197 16 27
GLIPIZIDE 249 202 17 20
ASPIRIN EC 238 194 18 26
ATENOLOL 220 185 19 12
DICLOFENAC POTASSIUM 216 164 20 45
SERTRALINE HCL 215 194 21 43
FUROSEMIDE 211 181 22 13
ISOSORBIDE MONONITRATE ER 200 192 23 21
WARFARIN SODIUM 187 168 24 46
ALENDRONATE SODIUM 181 166 25 19
LISINOPRIL 167 144 26 14
LANTUS 164 92 27 28
TRAMADOL HCL 157 118 28 32
PRAVASTATIN SODIUM 151 134 29 24
GLYBURIDE-METFORMIN HCL 149 107 R 30 48
CLOPIDOGREL 147 146 31 30
DONEPEZIL HCL 144 142 32 50
FOSINOPRIL SODIUM 142 113 33 89
AMLODIPINE BESYLATE-BENAZEPRIL 140 108 34 42
PLAVIX 138 127 35 33
PENTOXIFYLLINE 131 99 36 73
IRBESARTAN 130 120 37 51
HUMULIN 70-30 130 104 37 35
NABUMETONE 115 80 39 37
DOXAZOSIN MESYLATE 112 80 40 25
CLOTRIMAZOLE-BETAMETHASONE 112 90 40 49
METOPROLOL TARTRATE 110 92 42 17
AZITHROMYCIN 104 66 43 55
TAMSULOSIN HCL 103 92 44 38
CARVEDILOL 99 94 45 22
PANTOPRAZOLE SODIUM 98 76 46 36
GEMFIBROZIL 93 60 47 61
FAMOTIDINE 92 79 48 31
COUMADIN 90 83 49 88
SINGULAIR 88 61 50 58
VERAPAMIL ER 81 56 51 39
DIGOXIN 79 63 52 44
QUINAPRIL HCL 78 77 53 104
OXYCODONE-ACETAMINOPHEN 77 23 S2 54 102
ADVAIR DISKUS 74 27 55 97
HUMALOG 74 40 55 101
LYRICA 70 55 57 86
CIPROFLOXACIN HCL 66 58 58 54
METOCLOPRAMIDE HCL 64 48 59 107
MECLIZINE HCL 62 58 60 56
FENOFIBRATE 62 44 60 34
PROAIR HFA 60 26 62 92
DIOVAN 59 43 63 57
INSULIN SYRINGE 59 35 63 41
AVAPRO 58 57 65 83
DILTIAZEM HCL 57 54 66 106
NAMENDA 57 57 66 94
FLUTICASONE PROPIONATE 56 38 68 66
LANSOPRAZOLE 51 37 69 72
RAMIPRIL 50 35 70 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.